News search

    E.g., 30/11/2024
    E.g., 30/11/2024
    Catarina Tristão Pereira, Enrique Lara Pezzi, Raquel Toribio Fernández, Borja Ibáñez, Valentín Fuster, Sergio Callejas, Marta Cortés Canteli, Ana Dopazo, Pilar Martín, Inés García Lunar e Irene Fernández Nueda.
    Research
    23 Jan 2024
    Circulation Research: APOE genetic variants linked to Alzheimer disease are also associated with the development of subclinical aterosclerosis

    The most potent genetic risk factor for Alzheimer disease, APOE4, is associated with an elevated risk of developing subclinical atherosclerosis in middle age, whereas the Alzheimer-protective variant of the same gene, APOE2, protects against subclinical atherosclerosis
    David Sancho
    About the CNIC
    19 Jan 2024
    The ImnovAth project, led by Dr. David Sancho, has been selected by the ERC for its Proof of Concept grants

    The ImnovAth project seeks an innovative approach to treat atherosclerosis
    Ayelén M. Santamans y Guadalupe Sabio
    Research
    19 Jan 2024
    Science Advances: First therapeutic target for preserving heart function in patients with pulmonary hypertension

    A team led by scientists from the CNIC and CNIO has identified a potential therapeutic target that protects the heart in patients with pulmonary hypertension
    About the CNIC
    18 Jan 2024
    Don´t miss the new videos showcasing research at the CNIC
    Research
    3 Jan 2024
    EMBO Molecular Medicine: Accumulation of the protein versican is the cause of aortic aneurysm in Marfan syndrome

    A team led by scientists at the CNIC and CSIC has found that accumulation of versican in the aortas of Marfan syndrome patients triggers the activation of the nitric oxide pathway through the activation of the the protein AKT

    Juan Pedro Bolaños
    About the CNIC
    2 Jan 2024
    Juan Pedro Bolaños: "We often think we have a God-given understanding of how to do certain things"

    Juan Pedro Bolaños is Professor of Biochemistry and Molecular Biology at the University of Salamanca.
    Edward Pearce
    Research
    21 Dec 2023
    Edward Pearce: "Prevention is always more economical than treating a heart attack or a heart transplant"

    Johns Hopkins UniversityBloomberg School of Public HealthBaltimore
    Roser Vento-Tormo
    Research
    20 Dec 2023
    Roser Vento-Tormo: "Working in academic science is a privilege, as it allows us to develop our creative side"
    Rafael Yuste
    Research
    19 Dec 2023
    Rafael Yuste: “Because it accesses the centre of our mental activity, neurotechnology bypasses all of the filters that exist in the body
    Carla Rothlin
    About the CNIC
    19 Dec 2023
    Carla Rothlin: “Research is an intellectual challenge that you can take up throughout your life”

    Dr. Carla Rothlin is Dorys McConnell Duberg Professor of Immunobiology and Professor of Pharmacology at the Yale School of Medicine, and co-leader of the Cancer Immunology Programme at Yale Cancer Centre. She studied biochemistry and pharmacology at the University of Buenos Aires, where she also undertook her postgraduate research under the direction of Dr. Ana Belén Elgoyhen, focussing on nicotinic receptors expressed in the inner ear. Later, she completed her doctorate and moved to San Diego to join Dr. Greg Lemke’s laboratory at the Salk Institute for Biological Studies. In 2009, Dr. Rothlin was named Assistant Professor in Immunobiology at Yale Medical School